OACC

Oaktree Acquisition Corp. III Life Sciences

$10.70

0.00%
SectorFinancial ServicesIndustryShell CompaniesCountryUnited States

Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was founded in 1995 and is headquartered in Los Angeles, California.

Source: Yahoo Finance
Q-Score—/ 100
Market Cap$141.8M
P/E20.99
Dividend Yield0.00%
52-Week Range—
Next Earnings—
Analysts—
Beta0.04
AI summary

Price & performance

1M-0.4%
3M-0.2%
YTD+1.0%
1Y+1.3%
52-week range—
Beta0.04
Full chart and returns against a benchmark

Q-Score

—/ 100

Quality against peers; 50 is the peer median.

Growth—
Risk58
Performance47
Valuation54
Profitability—
Leverage—
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · Q2 2026

Revenue—
Net income$1.6M
Net margin—
Historical fundamentals

Red flags in filings

1active red flag
Going-concern doubtMar 26, 2026
Filings, findings and the timeline

Valuation

OACCIndustryP/E20.9964.76P/S——EV/EBITDA——P/B——PEG——
Dividend yield0.00%
Every valuation metric